Earnings Calendar - Mar 24, 2026
Showing earnings announcements on Mar 24, 2026
Name | Price | % Change | Company | Market Cap | EPS / Forecast | Revenue / Forecast | Time | Analyst Consensus | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
 | $24.70 | GameStop | $12.44B | xxxxxxxxxxxxx | ||||||
 | $11.90 | COMPASS Pathways | $1.72B | xxxxxxxxxxxxx | ||||||
 | $129.05 | Dollarama | $35.02B | xxxxxxxxxxxxx | ||||||
 | $7.24 | Achieve Life Sciences | $832.48M | xxxxxxxxxxxxx | ||||||
 | $25.42 | Braze | $2.85B | xxxxxxxxxxxxx | ||||||
 | $11.07 | AbSci | $1.85B | xxxxxxxxxxxxx | ||||||
 | $0.59 | Vertical Aerospace | $101.07M | xxxxxxxxxxxxx | ||||||
 | $1.27 | Biomea Fusion | $96.40M | xxxxxxxxxxxxx | ||||||
 | $14.23 | Paysign | $761.11M | xxxxxxxxxxxxx | ||||||
 | $11.20 | Velo3D | $350.10M | xxxxxxxxxxxxx | ||||||
 | $45.75 | KB Home | $2.83B | xxxxxxxxxxxxx | ||||||
 | $2.28 | Comstock Mining | $176.30M | xxxxxxxxxxxxx | ||||||
 | $2.91 | NRX Pharmaceuticals | $126.42M | xxxxxxxxxxxxx | ||||||
 | $102.51 | AAR | $4.08B | xxxxxxxxxxxxx | ||||||
 | $25.65 | Neurogene | $556.72M | xxxxxxxxxxxxx | ||||||
 | $0.48 | Blaize Holdings | $69.07M | xxxxxxxxxxxxx | ||||||
 | $0.41 | Fractyl Health, Inc. | $86.66M | xxxxxxxxxxxxx | ||||||
 | $15.38 | Hesai Group Sponsored ADR | $2.50B | xxxxxxxxxxxxx | ||||||
 | $24.91 | Concentrix | $1.52B | xxxxxxxxxxxxx | ||||||
 | $0.72 | Intrusion | $17.65M | xxxxxxxxxxxxx | ||||||
 | $1.04 | BioCardia | $15.29M | xxxxxxxxxxxxx | ||||||
 | $15.35 | Xiaomi Corp. Unsponsored ADR Class B | $82.20B | xxxxxxxxxxxxx | ||||||
 | $1.66 | Spectral AI | $53.43M | xxxxxxxxxxxxx | ||||||
 | $0.70 | Reed's | $7.80M | xxxxxxxxxxxxx | ||||||
 | $2.73 | BioStem Technologies | $55.10M | xxxxxxxxxxxxx | ||||||
 | $0.85 | Canada Nickel Company | $225.54M | ― | ― | xxxxxxxxxxxxx | ||||
 | $10.20 | Fennec Pharmaceuticals | $373.47M | xxxxxxxxxxxxx | ||||||
 | $60.66 | Worthington Industries | $2.91B | xxxxxxxxxxxxx | ||||||
 | <$0.01 | Strata Skin Sciences | $29.44K | ― | xxxxxxxxxxxxx | |||||
 | $0.26 | Silexion Therapeutics | $3.06M | xxxxxxxxxxxxx | ||||||
 | $5.29 | Draganfly | $227.67M | xxxxxxxxxxxxx | ||||||
 | $18.86 | Smithfield Foods | $7.37B | xxxxxxxxxxxxx | ||||||
 | $41.35 | Core & Main | $7.90B | xxxxxxxxxxxxx | ||||||
 | $29.94 | Skeena Resources | C$3.73B | xxxxxxxxxxxxx | ||||||
 | $2.64 | Integra Resources Corp | C$526.13M | xxxxxxxxxxxxx | ||||||
 | $1.14 | TELA Bio | $51.91M | xxxxxxxxxxxxx | ||||||
 | $77.11 | M-tron Industries Inc | $340.16M | xxxxxxxxxxxxx | ||||||
 | $5.74 | Epsilon Energy | $175.65M | xxxxxxxxxxxxx | ||||||
 | $1.67 | Heidmar Maritime Holdings Corp. | $98.52M | xxxxxxxxxxxxx | ||||||
 | $15.56 | Perma-Fix | $332.07M | xxxxxxxxxxxxx | ||||||
 | $22.18 | Cadeler A/S Sponsored ADR | $2.09B | xxxxxxxxxxxxx | ||||||
 | $1.07 | MaxCyte | $115.59M | xxxxxxxxxxxxx | ||||||
 | $1.93 | CNFinance Holdings | $32.87M | ― | xxxxxxxxxxxxx | |||||
 | $1.83 | Aimia Inc. | C$162.28M | xxxxxxxxxxxxx | ||||||
 | $34.85 | Sanara MedTech | $322.87M | xxxxxxxxxxxxx | ||||||
 | $1.40 | BrilliA Inc. Class A | $42.26M | xxxxxxxxxxxxx | ||||||
 | $8.73 | Kingfisher | $7.21B | xxxxxxxxxxxxx | ||||||
 | $18.17 | Elemental Royalties | $1.38B | xxxxxxxxxxxxx | ||||||
 | $5.67 | Dominion Lending Centres, Inc. (Canada) Class A | C$481.33M | xxxxxxxxxxxxx | ||||||
 | $0.33 | Rubicon Organics | $23.18M | xxxxxxxxxxxxx | ||||||
 | $5.49 | Glass House Brands | $411.91M | xxxxxxxxxxxxx | ||||||
 | $16.91 | WH Group | $10.83B | xxxxxxxxxxxxx | ||||||
 | $3.40 | Mount Logan Capital Inc | $38.15M | xxxxxxxxxxxxx | ||||||
 | $10.04 | Anhui Conch Cement Company Limited | $12.94B | xxxxxxxxxxxxx |
Rows:
Earnings News
FAQ
When is Earnings Season?
The earnings season usually begins one to two weeks after the end of the last month of each quarter (December, March, June, and September).
How do earnings affect stock prices?
A company's earnings report reveals its profitability and financial stability. If a company’s earnings are reported above expectations, its stock price tends to rise. However, depending on forward guidance and macroeconomic factors, a stock price is still susceptible to volatility.
Is it better to buy a stock before or after earnings?
Stock prices tend to be more volatile before and after a company reports its earnings. Investors should develop an investment thesis using Earnings Reports Insights and other datasets before making any investment decisions.